[HTML][HTML] Parkinson disease-associated cognitive impairment
Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
Prevalence of anxiety in Parkinson's disease: a systematic review and meta‐analysis
MPG Broen, NE Narayen, ML Kuijf… - Movement …, 2016 - Wiley Online Library
Objective Prevalence rates of anxiety disorders in Parkinson's disease (PD) vary widely,
ranging from 6% up to 55%. The aim of this systematic review was to calculate the average …
ranging from 6% up to 55%. The aim of this systematic review was to calculate the average …
Gut microbiota are related to Parkinson's disease and clinical phenotype
In the course of Parkinson's disease (PD), the enteric nervous system (ENS) and
parasympathetic nerves are amongst the structures earliest and most frequently affected by …
parasympathetic nerves are amongst the structures earliest and most frequently affected by …
Gut microbiota in Parkinson's disease: temporal stability and relations to disease progression
Background Several publications have described differences in cross-sectional
comparisons of gut microbiota between patients with Parkinson's disease and control …
comparisons of gut microbiota between patients with Parkinson's disease and control …
The O nset of N onmotor S ymptoms in P arkinson's disease (T he ONSET PD S tudy)
C Pont‐Sunyer, A Hotter, C Gaig, K Seppi… - Movement …, 2015 - Wiley Online Library
Nonmotor symptoms (NMS) in Parkinson's disease (PD) can precede onset of motor
symptoms. Relationship between premotor symptoms onset and motor features is limited …
symptoms. Relationship between premotor symptoms onset and motor features is limited …
Fatigue in Parkinson's disease: a systematic review and meta‐analysis
We conducted a systematic review and meta‐analysis aimed at establishing robust
prevalence estimates and identifying clinical correlates of fatigue in PD. From 2,459 titles …
prevalence estimates and identifying clinical correlates of fatigue in PD. From 2,459 titles …
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
K Seppi, D Weintraub, M Coelho… - Movement …, 2011 - Wiley Online Library
Abstract The Movement Disorder Society (MDS) Task Force on Evidence‐Based Medicine
(EBM) Review of Treatments for Parkinson's Disease (PD) was first published in 2002 and …
(EBM) Review of Treatments for Parkinson's Disease (PD) was first published in 2002 and …
The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease
Background: Non‐motor symptoms are detrimental to health‐related quality of life (HRQoL)
of Parkinson's disease patients. In this study, the Non‐Motor Symptoms Scale (NMSS) was …
of Parkinson's disease patients. In this study, the Non‐Motor Symptoms Scale (NMSS) was …
Non-motor symptoms of Parkinson's disease: diagnosis and management
The clinical diagnosis of Parkinson's disease rests on the identification of the characteristics
related to dopamine deficiency that are a consequence of degeneration of the substantia …
related to dopamine deficiency that are a consequence of degeneration of the substantia …
Premotor and nonmotor features of Parkinson's disease
Premotor and nonmotor features of Parkinson's disease : Current Opinion in Neurology
Premotor and nonmotor features of Parkinson's disease : Current Opinion in Neurology Log in or …
Premotor and nonmotor features of Parkinson's disease : Current Opinion in Neurology Log in or …